HBL Hadasit Bio Holdings

Hadasit Bio-Holdings Ltd. (HBL) is an Israeli biotechnology investment company that was founded and listed on the Tel Aviv Stock Exchange (TASE: HDST) and subsequently on the US OTC market (OTCBB: HADSY) to allow public participation in the biotechnology field. HBL invests in companies commercializing biomedical innovations originating from Hadassah Medical Center, one of Israel's leading academic medical institutions, and other research institutions. The company targets early-stage life sciences ventures developing therapeutics, diagnostics, and medical devices based on promising scientific research and intellectual property. HBL serves as a bridge between academic biomedical research and commercial development, providing capital and strategic support to translate research discoveries into clinical and commercial products.